Catalyst Wire Dossier Catalyst Wire Dossier

Laser-Assisted Immunotherapy (LIT/inCVAX)

· Eske Corporation S.A.C
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Laser-Assisted Immunotherapy (LIT/inCVAX), covering 2018-02-23 to 2018-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer [Phase 3]

See pricing